Register to leave comments

  • News bot Oct. 1, 2025, 4:09 p.m.

    📋 SPECTRUM PHARMACEUTICALS INC (SPPI) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 16:29:26

    Event Type: Financial Results

    Event Details:

    Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI) Reports Q2 2022 Financial Results Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 78679
      • targeting HER2 exon20 mutations•The New Drug Application (NDA) for poziotinib is under active review at the FDA with Fast Track designation. The NDA is based on the positive results of Cohort 2 in patients with previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 20 insertion mutations. The agency has set a PDUFA date of November 24, 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Selling General Administrative 9.87K 9.87K $0.00 +0.00%
    Total Operating Expenses 14.06K 33.69K $-19.62K -58.25%
    Net Loss -15.44K -15.44K $0.00 +0.00%
    Basic And Diluted Loss Per Share Net Loss Per Share -0.09 -0.09 $0.00 +0.00%
    Prepaid Expenses Other Current Assets 3.33K 2.28K $1.05K +46.16%
    Property Equipment Net 418.00 455.00 $-37.00 -8.13%
    Other Assets 4.35K 4.64K $-288.00 -6.21%
    Other Long Term Liabilities 5.59K 10.77K $-5.18K -48.08%
    Selling, General & Administrative 9.87K 14.31K $-4.45K -31.05%
    Total Operating Expenses 14.06K 33.69K $-19.62K -58.25%
    Interest Income 11.00 84.00 $-73.00 -86.90%
    Net Loss -15.44K -35.70K $20.25K +56.74%
    Prepaid Expenses and Other Current Assets 3.33K 2.28K $1.05K +46.16%
    Property and Equipment, Net 418.00 455.00 $-37.00 -8.13%
    Other Assets 4.35K 4.64K $-288.00 -6.21%
    Accounts Payable 32.58K 41.26K $-8.68K -21.05%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023)
    • CIK: 0000831547
    • Ticker Symbol: SPPI
    • Period End Date: 2022-05-12
    • Document Type: 8-K